New technique protects synthetic gene circuits against cell growth dilution

Genetic engineers can design and assemble sophisticated gene circuits to program cells with new functions, but important ...

Tissue 'tipping points': How cells collectively switch from healthy to disease states

Cells convert mechanical forces into signals that influence physiological processes, such as exercise strengthening bones. A ...
Nature

First ever atlas of brain development shows how stem cells turn into neurons

A collection of studies that chart how mammalian brain cells grow and differentiate is a ‘very valuable’ tool for ...
FierceBiotech

Immatics' cell therapy leapfrogs into phase 3 on strength of early-stage survival data

Immatics has vaulted into phase 3 on the strength of early-stage data. The biotech is gearing up to start a pivotal trial of its melanoma cell therapy IMA203 this year in light of the response and ...
Rutgers University

Landmark Data from Rutgers Cancer Institute and RWJBarnabas Health Show Long-term Complete Responses of T Cell Therapies for HPV-Related Cancers

Researchers from Rutgers Cancer Institute, New Jersey’s only National Cancer Institute (NCI) - designated Comprehensive ...
Nasdaq

Fate Therapeutics Presents New Phase 1 Clinical Data of FT819 Off-the-shelf, CAR T-cell Product Candidate for Systemic Lupus Erythematosus

SAN DIEGO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent ...

Scientists complete first drafts of developing mammalian brain cell atlases

A global consortium of scientists has created the first and most detailed "developmental maps" of the mammalian brain (from ...

Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma

CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has ...

Lung cancer's earliest stages may be driven by inflammation

By creating high-resolution cellular and molecular visual maps of lung cancer before and during development, researchers at ...

Normunity announces first patient dosed in Phase 1 clinical study of NRM-823, a T Cell Engager against a novel tumor-specific target, in patients with solid tumors

Phase 1a/1b study will evaluate NRM-823 as monotherapy and in combination with immune checkpoint inhibition in patients with locally-advanced or metastatic refractory solid tumors NRM-823 is a T cell ...